Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Catalent SG&A Expenses 2012-2024 | CTLT

Catalent annual/quarterly sg&a expenses history and growth rate from 2012 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • Catalent sg&a expenses for the quarter ending March 31, 2024 were $0.214B, a 12.63% increase year-over-year.
  • Catalent sg&a expenses for the twelve months ending March 31, 2024 were $886M, a 5.73% increase year-over-year.
  • Catalent annual sg&a expenses for 2023 were $0.829B, a 1.78% decline from 2022.
  • Catalent annual sg&a expenses for 2022 were $0.844B, a 22.85% increase from 2021.
  • Catalent annual sg&a expenses for 2021 were $0.687B, a 19.06% increase from 2020.
  
Catalent Annual SG&A Expenses
(Millions of US $)
2023 $829
2022 $844
2021 $687
2020 $577
2019 $512
2018 $465
2017 $403
2016 $358
2015 $337
2014 $335
2013 $341
2012 $348
2011 $288
Catalent Quarterly SG&A Expenses
(Millions of US $)
2024-03-31 $214
2023-12-31 $250
2023-09-30 $205
2023-06-30 $217
2023-03-31 $190
2022-12-31 $226
2022-09-30 $196
2022-06-30 $226
2022-03-31 $207
2021-12-31 $228
2021-09-30 $183
2021-06-30 $184
2021-03-31 $173
2020-12-31 $165
2020-09-30 $165
2020-06-30 $157
2020-03-31 $136
2019-12-31 $141
2019-09-30 $143
2019-06-30 $143
2019-03-31 $130
2018-12-31 $123
2018-09-30 $116
2018-06-30 $125
2018-03-31 $118
2017-12-31 $115
2017-09-30 $108
2017-06-30 $107
2017-03-31 $101
2016-12-31 $96
2016-09-30 $98
2016-06-30 $89
2016-03-31 $93
2015-12-31 $93
2015-09-30 $82
2015-06-30 $87
2015-03-31 $81
2014-12-31 $88
2014-09-30 $81
2014-06-30 $79
2014-03-31 $88
2013-12-31 $88
2013-09-30 $81
2013-06-30
2013-03-31
2012-06-30
2011-06-30
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $10.048B $4.276B
Catalent, Inc. is a renowned global provider of advanced delivery technologies as well as development and manufacturing solutions for drugs (protein, cell, and gene therapy biologics) and consumer health products.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.055B 31.33
Chugai Pharmaceutical (CHGCY) Japan $50.402B 22.53
Takeda Pharmaceutical (TAK) Japan $42.567B 8.62
Merck (MKGAF) Germany $22.335B 21.08
Astellas Pharma (ALPMY) Japan $17.626B 27.83
Sandoz Group AG (SDZNY) Switzerland $15.210B 0.00
Neurocrine Biosciences (NBIX) United States $13.936B 38.15
Shionogi (SGIOY) Japan $13.831B 12.02
United Therapeutics (UTHR) United States $11.966B 12.76
Cerevel Therapeutics Holdings (CERE) United States $7.670B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.061B 7.76
Revolution Medicines (RVMD) United States $6.167B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Ionis Pharmaceuticals (IONS) United States $5.586B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.496B 0.00
Alpine Immune Sciences (ALPN) United States $4.455B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.894B 0.00
Summit Therapeutics (SMMT) United States $3.289B 0.00
Corcept Therapeutics (CORT) United States $2.880B 26.09
Arrowhead Pharmaceuticals (ARWR) United States $2.845B 0.00
Dyne Therapeutics (DYN) United States $2.461B 0.00
Indivior (INDV) United States $2.417B 11.46
PTC Therapeutics (PTCT) United States $2.391B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.358B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.103B 12.02
Evotec AG (EVO) Germany $1.967B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.948B 18.95
NewAmsterdam Pharma (NAMS) Netherlands $1.830B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.823B 0.00
Ardelyx (ARDX) United States $1.813B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.591B 27.85
Avadel Pharmaceuticals (AVDL) Ireland $1.460B 0.00
Soleno Therapeutics (SLNO) United States $1.453B 0.00
Pacira BioSciences (PCRX) United States $1.435B 13.64
4D Molecular Therapeutics (FDMT) United States $1.331B 0.00
Xencor (XNCR) United States $1.255B 0.00
Enliven Therapeutics (ELVN) United States $1.122B 0.00
Cronos Group (CRON) Canada $1.119B 0.00
Cassava Sciences (SAVA) United States $1.119B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.106B 0.00
Collegium Pharmaceutical (COLL) United States $1.089B 6.51
Ironwood Pharmaceuticals (IRWD) United States $1.038B 16.17
Centessa Pharmaceuticals (CNTA) United Kingdom $1.022B 0.00
ProKidney (PROK) United States $0.945B 0.00
Ocular Therapeutix (OCUL) United States $0.937B 0.00
USANA Health Sciences (USNA) United States $0.906B 14.82
ARS Pharmaceuticals (SPRY) United States $0.870B 0.00
Relay Therapeutics (RLAY) United States $0.844B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.742B 0.00
Sage Therapeutics (SAGE) United States $0.722B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.673B 0.00
Savara (SVRA) United States $0.665B 0.00
Lyell Immunopharma (LYEL) United States $0.648B 0.00
Silence Therapeutics (SLN) United Kingdom $0.633B 0.00
Exscientia (EXAI) United Kingdom $0.603B 0.00
Harrow (HROW) United States $0.575B 0.00
Siga Technologies (SIGA) United States $0.558B 7.14
Altimmune (ALT) United States $0.554B 0.00
OmniAb (OABI) United States $0.527B 0.00
KalVista Pharmaceuticals (KALV) United States $0.527B 0.00
Verve Therapeutics (VERV) United States $0.523B 0.00
Larimar Therapeutics (LRMR) United States $0.503B 0.00
Bioventus (BVS) United States $0.474B 18.15
Lexeo Therapeutics (LXEO) United States $0.460B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.459B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.456B 0.00
Heron Therapeutics (HRTX) United States $0.423B 0.00
Esperion Therapeutics (ESPR) United States $0.413B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.403B 0.00
Korro Bio (KRRO) United States $0.402B 0.00
Organogenesis (ORGO) United States $0.377B 71.12
Tourmaline Bio (TRML) United States $0.370B 0.00
Nanobiotix S.A (NBTX) France $0.344B 0.00
Nektar Therapeutics (NKTR) United States $0.325B 0.00
Black Diamond Therapeutics (BDTX) United States $0.323B 0.00
Fractyl Health (GUTS) United States $0.317B 0.00
Nature's Sunshine Products (NATR) United States $0.294B 18.70
Aquestive Therapeutics (AQST) United States $0.291B 0.00
Xeris Biopharma Holdings (XERS) United States $0.282B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.280B 0.00
ESSA Pharma (EPIX) Canada $0.265B 0.00
Akebia Therapeutics (AKBA) United States $0.258B 0.00
Aldeyra Therapeutics (ALDX) United States $0.248B 0.00
Pyxis Oncology (PYXS) United States $0.247B 0.00
Metagenomi (MGX) United States $0.245B 0.00
Foghorn Therapeutics (FHTX) United States $0.241B 0.00
Eliem Therapeutics (ELYM) United States $0.227B 0.00
Avita Medical (RCEL) United States $0.225B 0.00
Conduit Pharmaceuticals (CDT) United States $0.210B 0.00
Century Therapeutics (IPSC) United States $0.204B 0.00
Zevra Therapeutics (ZVRA) United States $0.201B 0.00
Profound Medical (PROF) Canada $0.201B 0.00
Adherex Technologies (FENC) United States $0.201B 244.67
Incannex Healthcare (IXHL) Australia $0.194B 0.00
Acrivon Therapeutics (ACRV) United States $0.189B 0.00
Telomir Pharmaceuticals (TELO) United States $0.187B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Galectin Therapeutics (GALT) United States $0.176B 0.00
Achieve Life Sciences (ACHV) Canada $0.172B 0.00
MediWound (MDWD) Israel $0.169B 0.00
CytoDyn (CYDY) United States $0.167B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.166B 0.00
Prelude Therapeutics (PRLD) United States $0.162B 0.00
VAXART, INC (VXRT) United States $0.153B 0.00
Elite Pharmaceuticals (ELTP) United States $0.149B 13.95
Cardiol Therapeutics (CRDL) Canada $0.149B 0.00
Regulus Therapeutics (RGLS) United States $0.136B 0.00
Karyopharm Therapeutics (KPTI) United States $0.128B 0.00
Context Therapeutics (CNTX) United States $0.128B 0.00
OptiNose (OPTN) United States $0.128B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.127B 8.50
FibroGen (FGEN) United States $0.117B 0.00
PMV Pharmaceuticals (PMVP) United States $0.110B 0.00
Relmada Therapeutics (RLMD) United States $0.110B 0.00
Citius Pharmaceuticals (CTXR) United States $0.109B 0.00
Vivani Medical (VANI) United States $0.101B 0.00
ProPhase Labs (PRPH) United States $0.097B 0.00
Assertio Holdings (ASRT) United States $0.096B 4.39
AlloVir (ALVR) United States $0.089B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Jaguar Animal Health (JAGX) United States $0.076B 0.00
Tempest Therapeutics (TPST) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.074B 1.05
Marinus Pharmaceuticals (MRNS) United States $0.074B 0.00
Journey Medical (DERM) United States $0.072B 0.00
Protara Therapeutics (TARA) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
Carisma Therapeutics (CARM) United States $0.061B 0.00
Inotiv (NOTV) United States $0.055B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.054B 0.00
BioLineRx (BLRX) Israel $0.052B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.051B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
CASI Pharmaceuticals (CASI) China $0.042B 0.00
Gain Therapeutics (GANX) United States $0.042B 0.00
VYNE Therapeutics (VYNE) United States $0.042B 0.00
Unicycive Therapeutics (UNCY) United States $0.041B 0.00
Nutriband (NTRB) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.035B 0.00
NRx Pharmaceuticals (NRXP) United States $0.034B 0.00
Surrozen (SRZN) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
Lipocine (LPCN) United States $0.029B 0.00
DURECT (DRRX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
JanOne (JAN) United States $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
Aptorum Group (APM) United Kingdom $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
Lyra Therapeutics (LYRA) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.021B 0.81
PolyPid (PYPD) Israel $0.021B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.017B 0.00
CERo Therapeutics Holdings (CERO) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.013B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.004B 0.00
Clever Leaves Holdings (CLVR) Canada $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.29
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 36.17